Aldevron’s Post

ICYMI As mRNA-based medicines move toward clinical development stages, the question of defining quality attributes and analytical testing procedures become ever more important. As part of an ongoing series discussing mRNA manufacturing, Nate Spangler looks at the state of those elements and what the future could hold for implementation. https://ald.bio/3UOUzGC

Taking mRNA’s Measurements

Taking mRNA’s Measurements

aldevron.com

To view or add a comment, sign in

Explore topics